As of November 2024, Xvivo Perfusion AB has a market cap of $1.52B. This makes Xvivo Perfusion AB the world's 6134th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $833.12M | -18.06% |
2023 | $1.02B | 80.05% |
2022 | $564.67M | -34.29% |
2021 | $859.34M | -11.31% |
2020 | $968.88M | 84.71% |
2019 | $524.55M | 28.79% |
2018 | $407.30M | 40.43% |
2017 | $290.05M | 6.82% |
2016 | $271.53M | 50.43% |
2015 | $180.51M | 70.55% |
2014 | $105.84M | 2.39% |
2013 | $103.37M | 65.84% |
2012 | $62.33M | - |